INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
  3. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

Form 4 transactions

18,921 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
4
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$31K
100 sh
Jul 1, 2026Jul 6, 2026
Page 187 of 474
← PrevNext →
traded Jul 1, 2026
+5d
SEC Form 4

Evidence

4
RA
Reardon AndrewCLO & Secretary
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$32K
104 sh
Jul 1, 2026Jul 6, 2026
traded Jul 1, 2026
+5dSEC Form 4

Evidence

3
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$31K
326 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

3
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$9,483
100 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

3
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$29K
310 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

3
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$25K
274 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

3
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
137 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

3
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$5,734
59 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

3
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$39K
425 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

3
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$49K
529 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

3
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$9,391
99 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

3
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$39K
428 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

3
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$19K
199 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

3
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$5,151
53 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

3
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$7,331
2,461 sh
Jul 2, 2026Jul 6, 2026
traded Jul 2, 2026
+4dSEC Form 4

Evidence

1
BK
Bliss KellyPresident, U.S. Group Health
TDOCTeladoc Health, Inc.
Open-market sale · 10b5-1 plan
SELL$24K
2,500 sh
Jul 6, 2026Jul 6, 2026
traded Jul 6, 2026
+0dSEC Form 4

Evidence

33
CJ
Casey Patrick JohnDirector
LEGNLegend Biotech Corp
Open-market sale
SELL$89K
6,000 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

32
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale
SELL$3.17M
60.0K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

32
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale
SELL$2.13M
40.0K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

32
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale
SELL$3.14M
60.0K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

32
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale
SELL$3.17M
60.0K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

32
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale
SELL$3.14M
60.0K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

32
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale
SELL$2.15M
40.0K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

32
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Open-market sale
SELL$2.15M
40.0K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

32
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Open-market sale
SELL$2.13M
40.0K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

21
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$400K
13.4K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

21
NA
Narayanan ArunChief Executive Officer
STEMSTEM, INC.
Open-market sale
SELL$16K
1,996 sh
Jul 2, 2026Jul 2, 2026
traded Jul 2, 2026
+0dSEC Form 4

Evidence

19
RM
Rogers Daniel MarkDirector, Chief Executive Officer
ASANAsana, Inc.
Open-market sale · 10b5-1 plan
SELL$95K
13.8K sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

19
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$4.80M
56.5K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

19
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$1.60M
18.7K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

17
LJ
Lopez Gustavo JavierDirector
LNDBrasilAgro - Brazilian Agricultural Real Estate Co
Open-market sale
SELL$6,980
2,000 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

16
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$723K
90.0K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

15
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
1,200 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

13
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$64K
741 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

13
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
2,438 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

9
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
2,437 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence

4
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$327K
3,900 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

4
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$290K
3,500 sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

4
KZ
Katz ZacharyCLO and Head of Global Affairs
GRNDGrindr Inc.
Open-market sale · 10b5-1 plan
SELL$208K
12.8K sh
Jul 1, 2026Jul 2, 2026
traded Jul 1, 2026
+1dSEC Form 4

Evidence

0
SE
Schubach Sarah ElizabethChief Accounting Officer
DBXDROPBOX, INC.
Open-market sale · 10b5-1 plan
SELL$35K
1,305 sh
Jun 30, 2026Jul 2, 2026
traded Jun 30, 2026
+2dSEC Form 4

Evidence